Foundation of a new company from BLS-Analytik GmbH, TentaMedix GmbH and DSIpharm Oldenburg
The Tentamus Group is pleased to announce that BLS Analytik GmbH, TentaMedix GmbH and DSIpharm Oldenburg are operating under the name Tentamus Pharma & Med Deutschland GmbH with immediate effect. The company's headquarters are in Bad Kissingen, Columbiastrasse 14 (97688), with two other locations in Karlsruhe (Am Hubengut 3, 76149) and Oldenburg (Würzburger Strasse 3, 26121). The managing directors are Dr. Sven Ash and Dr. Dominic Herzog.
dr Asche, former managing director of BLS Analytik GmbH, is delighted: "The merger is a great enrichment for our customers in the field of pharmaceutical manufacturing and biocompatibility testing of medical products. The range of methods and analyzes has become even larger through the merger of the three companies. Herzog, former managing director of TentaMedix GmbH, agrees: "Through the merger, we can offer our customers everything from a single source, with the consistently high quality of the analyzes and excellent customer communication."
The three locations of Tentamus Pharma & Med Deutschland GmbH are GMP-certified, Bad Kissingen and Karlsruhe are also DIN EN ISO/IEC 17025 accredited. The location in Bad Kissingen is able to offer its customers from the pharmaceutical industry and medical technology a wide range of analytical methods with the most modern equipment. The laboratory with its reliable and high-quality wet chemical and instrumental analysis (LC, GC, elemental analysis) will be an important part of the new company.
The Oldenburg site has a manufacturing license according to §13 AMG and can look back on many years of experience in the field of pharmaceutical development. In addition to the extensive portfolio of analytics, the Oldenburg site also offers rich experience in the field of method development and validation as well as in ICH-compliant stability studies.
The location in Karlsruhe offers a large portfolio of microbiological, molecular biological and bioanalytical methods. In addition, this location is accredited for in-vitro biocompatibility testing of medical products (DIN EN ISO 10993) and recognized by the ZLG. Thus, in addition to the chemical-analytical methods, the biological safety of drugs and medical products can also be examined by Tentamus Pharma & Med Deutschland GmbH.
Tentamus Pharma & Med Deutschland GmbH is therefore the right place to go for the testing of your pharmaceuticals and medical devices. We look forward to your inquiry.
Contact:
ppa. Isolde Pettinella
Project management
Email: isolde.pettinella@bls-analytik.de
Tel: + 49 - (0) 971 / 7 85 58 - 28
dr Nicolas Daniellec
Sales & Marketing
Project manager
E-mail: Nicolas.Danylec@tentamedix.com
Mobile: +49 – (0)151 / 4406 2260
Phone: + 49 - (0)721 / 957 919 - 550
